220 related articles for article (PubMed ID: 2713562)
21. The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia.
Saşmaz I; Tanyeli A; Bayram I; Antmen B; Yilmaz L; Küçükosmanoğlu O; Kilinç Y
Turk J Pediatr; 2004; 46(1):32-7. PubMed ID: 15074372
[TBL] [Abstract][Full Text] [Related]
22. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results of an induction combination regimen including fractionated anthracycline.
Krieger O; Bernhart M; Fiedler E; Kasparu H; Weber E; Lutz D
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610
[No Abstract] [Full Text] [Related]
24. [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].
Kumagawa M; Suzuki K; Nagano M; Takamatsu Y; Suzumiya J; Tamura K
Rinsho Ketsueki; 2003 Jun; 44(6):404-6. PubMed ID: 12884821
[TBL] [Abstract][Full Text] [Related]
25. Idarubicin in acute leukemia: results of US trials.
Berman E; Raymond V; Gee TS; Kempin SJ; Gulati S; Andreeff M; Gabrilove J; Young CW; Clarkson BD; Wiernik PH
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():49. PubMed ID: 2713561
[No Abstract] [Full Text] [Related]
26. Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.
Lee SH; Abebe L; Paietta E; Einzig A; Wiernik PH
Am J Hematol; 2009 Jul; 84(7):455-7. PubMed ID: 19507211
[No Abstract] [Full Text] [Related]
27. A phase II comparative study of idarubicin plus cytarabine versus daunorubicin plus cytarabine in adult acute myeloid leukemia.
Masaoka T; Ogawa M; Yamada K; Kimura K; Ohashi Y
Semin Hematol; 1996 Oct; 33(4 Suppl 3):12-7. PubMed ID: 8916311
[TBL] [Abstract][Full Text] [Related]
28. Outcome of acute myeloid leukaemia in adults: a retrospective analysis.
Saikia TK; Bakshi A; Bhagwat R; Tawde S; Nair R; Nair CN; Parikh PM
Natl Med J India; 2005; 18(1):12-5. PubMed ID: 15835484
[TBL] [Abstract][Full Text] [Related]
29. [The current chemotherapy of acute myeloid leukemias in adults].
Poddubnaia IV; Perilov AA
Ter Arkh; 1993; 65(7):86-9. PubMed ID: 8211791
[No Abstract] [Full Text] [Related]
30. Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
Haas R; Ho AD; Del Valle F; Fischer JT; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
Semin Oncol; 1993 Dec; 20(6 Suppl 8):20-6. PubMed ID: 8290968
[TBL] [Abstract][Full Text] [Related]
31. [Early phase II study of Idarubicin combined with cytarabine in acute myelogenous leukemia. Idarubicin Study Group].
Ogawa M; Masaoka T; Yamada K; Kimura K
Gan To Kagaku Ryoho; 1993 May; 20(7):907-14. PubMed ID: 8489297
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.
Romani C; Di Tucci AA; Dessalvi P; Pettinau M; Emanuele A
Am J Hematol; 2010 Mar; 85(3):219. PubMed ID: 20063278
[No Abstract] [Full Text] [Related]
33. High-dose cytarabine, idarubicin, and granulocyte colony-stimulating factor remission induction therapy for previously untreated de novo and secondary adult acute myeloid leukemia.
Baer MR; Christiansen NP; Frankel SR; Brunetto VL; Mrózek K; Bloomfield CD; Herzig GP
Semin Oncol; 1993 Dec; 20(6 Suppl 8):6-12. PubMed ID: 7507264
[TBL] [Abstract][Full Text] [Related]
34. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
[No Abstract] [Full Text] [Related]
35. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
Miyazaki Y
Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
[No Abstract] [Full Text] [Related]
36. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
[TBL] [Abstract][Full Text] [Related]
37. Treatment of refractory acute leukaemia with aclacinomycin A.
Rowe JM; Chang AY; Bennett JM
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():47-8. PubMed ID: 2627607
[No Abstract] [Full Text] [Related]
38. GM-IVA, a short induction course for de novo acute myeloid leukemia, suitable for the elderly.
Pierri I; Clavio M; Miglino M; Cavaliere M; Pietrasanta D; Gobbi M
Haematologica; 1999 Jun; 84(6):562-3. PubMed ID: 10366806
[No Abstract] [Full Text] [Related]
39. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
[TBL] [Abstract][Full Text] [Related]
40. A new combination of carboplatin, high-dose cytarabine and cross-over mitoxantrone or idarubicin for refractory and relapsed acute myeloid leukemia.
Bassan R; Lerede T; Buelli M; Borleri G; Bellavita P; Rambaldi A; Barbui T
Haematologica; 1998 May; 83(5):422-7. PubMed ID: 9658726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]